Updated · AI-assisted evidence analysis
Cosequin® for Dogs with MSM Plus Omega-3 Fatty Acid Soft Chews Review 2026: What Does the Evidence Show?
Cosequin's joint and coat claims go further than the dog research — Overhyped
-
"Helps support healthy cartilage in dogs"
A 2017 review of glucosamine and chondroitin in dogs called the evidence limited and conflicting, with few well-designed studies. An older review gave a moderate rating to one trial of a chondroitin, glucosamine and manganese ascorbate combination. MSM had no dog results in this search.
-
"Glucosamine plus chondroitin works in dogs with arthritis"
The main positive trial had 35 dogs, no placebo group (carprofen was the comparison) and vet-scored outcomes. It showed improvement by day 70, with a slower response than carprofen. It does not test this chew.
-
"Omega-3s help support skin and coat health"
Small dog trials of marine oil showed less itch and a better coat in dogs with skin disease. The two trials that reported amounts used roughly 66–85 mg/kg/day EPA+DHA. This chew has 55 mg EPA+DHA per chew, a small fraction of that at the label's serving sizes.
Double-blinded Crossover Study with Marine Oil Supplementation Containing High-dose icosapentaenoic Acid for the Treatment of Canine Pruritic Skin Disease. → · Effect of omega-3 fatty acids on canine atopic dermatitis. → · A placebo-controlled, double-blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs. → -
"#1 vet recommended and backed by science"
The page cites a vet survey with no method or sample details. No trial of this exact chew was found in this search, and the reviewed material shows no third-party test result for it.
Claims vs Evidence
2 claims assessed. Support depends on the study results, formulation, and population. Matching an ingredient or dose alone does not establish a benefit.
"Helps support healthy cartilage in dogs (joint health support)"
Stretch
Dog evidence for glucosamine and chondroitin is mostly for the two together, and reviews describe it as limited and conflicting. The one controlled trial measured pain, weight-bearing and severity scores by vet scoring, not cartilage, and had no placebo group. MSM has no dog evidence in what was retrieved. No trial of this exact product was found in this search.
Source: Cosequin® for Dogs with MSM Plus Omega-3 Fatty Acid Soft Chews: manufacturer product page →
Glucosamine/chondroitin vs carprofen in dogs with osteoarthritis
Randomised, double-blind, positive-controlled (carprofen), multicentre trial; no placebo group; subjective veterinarian scoring · ingredient
Significant improvement in pain, weight-bearing and severity scores by day 70 (P<0.001). Response was slower than with carprofen.
Limitations: Small sample, no placebo group, subjective vet scoring; methods and effect sizes unavailable in abstract; not this product
- Species
- dog
- Participants / condition
- 35 dogs with confirmed osteoarthritis of hips or elbows
- Formulation
- Glucosamine hydrochloride plus chondroitin sulfate combination; brand not stated in abstract
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- 70 days of treatment, re-assessed at day 98 after withdrawal
- Funding / conflicts
- Not reported in abstract; unavailable
Systematic review of clinical trials of osteoarthritis treatments in dogs
Systematic review of 16 prospective dog trials using FDA evidence-scoring · different formulation
Moderate level of comfort for the chondroitin/glucosamine/manganese ascorbate combination, based on one trial.
Limitations: Abstract only; one trial for this combination; older search; different formulation
- Species
- dog
- Participants / condition
- Dogs with osteoarthritis across 16 clinical trials
- Formulation
- One trial of chondroitin sulfate, glucosamine hydrochloride and manganese ascorbate combination; not this chew
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- Not reported; search ran to May 2006
- Funding / conflicts
- Not reported in abstract; unavailable
Glucosamine and chondroitin use in canines for osteoarthritis: a review
Narrative literature review · ingredient
Described the evidence as limited and conflicting, with few well-designed clinical studies.
Limitations: Abstract only; narrative review, not a pooled analysis
- Species
- dog
- Participants / condition
- Dogs with osteoarthritis, as covered by the reviewed literature
- Formulation
- Glucosamine HCl and chondroitin sulfate, various products
- Studied amount, not dosing advice
- Not reported in abstract
- Duration
- Not reported
- Funding / conflicts
- Not reported in abstract; unavailable
"Omega-3 fatty acids help support skin and coat health"
Stretch
Marine omega-3 has partial dog support for itch and coat, but the trials that reported amounts used about 66–85 mg/kg/day EPA+DHA, in dogs with allergic or atopic skin disease. The label gives 55 mg EPA+DHA per chew, far below those amounts at the label's serving sizes. No trial in healthy dogs or of this chew was found, so the claim can't rise above stretch.
Source: Cosequin® for Dogs with MSM Plus Omega-3 Fatty Acid Soft Chews: manufacturer product page →
Marine oil crossover trial for canine pruritic skin disease
Double-blinded crossover vs corn oil · ingredient
Better pruritus, alopecia and coat character than corn oil (P<0.02, <0.05, <0.001).
Limitations: Small sample; allergic dogs, not healthy dogs; abstract only; older trial
- Species
- dog
- Participants / condition
- 16 dogs with idiopathic pruritus, atopy and/or flea allergy
- Formulation
- Marine oil capsule, 180 mg EPA + 120 mg DHA each; not this chew
- Studied amount, not dosing advice
- One capsule per 4.55 kg daily, about 66 mg/kg/day EPA+DHA (calculated from reported figures)
- Duration
- 6 weeks per arm with 3-week washout
- Funding / conflicts
- Not reported in abstract; unavailable
Omega-3 fatty acids in canine atopic dermatitis
Double-blinded, placebo-controlled, randomised trial · ingredient
Clinical scores improved with flax oil and the EPA/DHA product, not with placebo. No link was found between total fatty acid intake and response.
Limitations: Small sample; atopic dogs; abstract only; coat not reported separately
- Species
- dog
- Participants / condition
- 29 dogs with atopic dermatitis
- Formulation
- Flax oil, or commercial EPA/DHA preparation; mineral oil placebo
- Studied amount, not dosing advice
- EPA 50 mg/kg/day plus DHA 35 mg/kg/day (85 mg/kg/day combined); flax oil 200 mg/kg/day
- Duration
- 10 weeks
- Funding / conflicts
- Not reported in abstract; unavailable
PUFA and oclacitinib dose in atopic dogs
Placebo-controlled, double-blind trial · ingredient
Itch score and coat quality improved only in the fish oil group. Skin lesion scores (CADESI-04) did not change or differ between groups.
Limitations: Small sample; dogs also on a drug; lesion scores unchanged; abstract only
- Species
- dog
- Participants / condition
- 22 client-owned dogs with atopic dermatitis on oclacitinib
- Formulation
- Fish oil product vs paraffin oil placebo; brand not stated in abstract
- Studied amount, not dosing advice
- EPA+DHA amount not reported in abstract
- Duration
- 16 weeks
- Funding / conflicts
- Not reported in abstract; unavailable
Signals
- The 'backed by science' and 'safe' statements rest on no exact-product trial found in this search; safety data for this chew were not in the reviewed material.
- '#1 veterinarian recommended' comes from a vet survey whose method and sample the page does not give.
- At 55 mg EPA+DHA per chew, omega-3 is well below the amounts used in the dog arthritis and skin trials described.
- The page shows no third-party test result for this product, and Nutramax was not on the NASC member list when checked.
- The label prints per-chew amounts for glucosamine (600 mg), MSM (400 mg), chondroitin (300 mg) and omega-3s (70 mg total, 55 mg EPA+DHA).
- The page gives a weight-based serving table, with a starting phase and a lower phase after 6 weeks.
Dose vs studies
Label amounts at the label's daily directions, per kg of body weight, compared with what dogs studies used. This compares the label with research. It is not dosing advice.
Label: 600 mg per chew
Studied: No established amount in dogs
Label: 400 mg per soft chew
Studied: No established amount in dogs
Label: 300 mg per soft chew
Studied: No established amount in dogs
Label: 55 mg per chew · about 2.1-6.1 mg/kg/day
Studied: 69 mg/kg/day EPA+DHA
Evidence checks
Species and formulation relevance
All study rows shown are dog research, but none tests this chew. Joint studies used glucosamine and chondroitin products of unstated brand or a different combination. Skin studies used marine oil at higher EPA+DHA amounts where reported. A 2022 meta-analysis pooled dogs and cats with no dog-only result in the excerpt, so it is not used as dog evidence here. No dog result for MSM was found in what was retrieved.
Label transparency
The label lists per-chew amounts for each active, including EPA and DHA. It names proprietary glucosamine and chondroitin specifications (FCHG49, TRH122) but gives no data on them. The survey behind the '#1' claims is not described beyond a short footnote.
Independent quality testing
No third-party test of this product appeared in the reviewed material. Nutramax Laboratories was not on the NASC member list when checked on 2026-11-03. That is a company-level record and says nothing about this product's contents.
Dose comparison with research
The reviewed abstracts gave no glucosamine, chondroitin or MSM amount to compare against the label. The label's 55 mg EPA+DHA per chew is below the 69 mg/kg/day EPA+DHA used in one dog arthritis trial and the roughly 66–85 mg/kg/day in the skin trials that reported amounts. This compares label and research amounts only; it is not dosing advice.
Sources (8)
- 1. Cosequin® for Dogs with MSM Plus Omega-3 Fatty Acid Soft Chews: manufacturer product page →
Manufacturer · Accessed 2026-11-04
- 2. NASC member list, checked 2026-11-03 →
Quality standard · Accessed 2026-11-03
- 3. Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. →
Study · Accessed 2026-11-04
- 4. Systematic review of clinical trials of treatments for osteoarthritis in dogs. →
Research review · Accessed 2026-11-04
- 5. Glucosamine and chondroitin use in canines for osteoarthritis: A review. →
Research review · Accessed 2026-11-04
- 6. Effect of omega-3 fatty acids on canine atopic dermatitis. →
Study · Accessed 2026-11-04
- 7. Double-blinded Crossover Study with Marine Oil Supplementation Containing High-dose icosapentaenoic Acid for the Treatment of Canine Pruritic Skin Disease. →
Study · Accessed 2026-11-04
- 8. A placebo-controlled, double-blind study evaluating the effect of orally administered polyunsaturated fatty acids on the oclacitinib dose for atopic dogs. →
Study · Accessed 2026-11-04
How this report was produced
AI-assisted evidence analysis. We reviewed published material, not physical products.
Automated source and evidence checks completed on 2026-11-04. These checks are not veterinary review.
Research scope and outstanding checks
Searched Europe PMC-style queries for canine osteoarthritis nutraceutical systematic reviews and for Cosequin in dogs, plus omega-3 skin and joint studies in dogs. Most sources were abstracts only, so methods, effect sizes and funding are often unavailable. The search was not exhaustive. Excluded as not applicable: unrelated osteoarthritis treatments, prevalence and diabetes studies, a 2002 beagle pharmacokinetic study of Cosequin (absorption, not efficacy), and a pooled dog-and-cat meta-analysis with no dog-only result in the excerpt. No exact-product trial of this chew was found in this search.
Focused research searches:
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- (Cosequin) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
- (Cosequin) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
- A controlled dog trial of this exact chew.
- Dog evidence for MSM.
- Omega-3 research at the amount this chew provides.
- Details of the vet survey behind the '#1' claims.
- A third-party test result for this product.